Medical Student Research Forum Posters

According to the CDC, chlamydia and gonorrhea are the most reported bacterial STIs in the United States and their rates are increasing. The CDC guidelines were updated in December 2020 to suggest a single IM dose of 500mg of ceftriaxone for treatment of gonorrhea, and if chlamydial infection is not excluded, a dual therapy combined with 100mg doxycycline 2x/day for 7 days. Inappropriate antibiotic use has contributed to growing resistance. It is important for health care providers to follow evidence-based treatment guidelines to prevent further AMR and ensure the best possible outcomes for patients. But are providers away of these new guidelines and have they accepted them into their practice? This exploratory study aims to determine how providers with different levels of background and experience will treat gonorrhea and chlamydia infections.